Evidence map›Paper›PMID 32941599›Full record

ArticleThe Journal of experimental medicine2020

Multi-omic comparison of Alzheimer's variants in human ESC-derived microglia reveals convergence at APOE.

Tongfei Liu, Bing Zhu, Yan Liu, Xiaoming Zhang, Jun Yin, Xiaoguang Li, LuLin Jiang, Andrew P Hodges, Sara Brin Rosenthal, Lisa Zhou and 6 more

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in The Journal of experimental medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed, 2 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 2 syntheses or guidelines pooled it, 70 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Microglial phagocytosis in Alzheimer disease.Nature reviews. Neurology · 2026
    Review
  10. Article
  11. Roles of TREM2 in Alzheimer's disease.Translational neurodegeneration · 2025
    Review
  12. Review
  13. Review
  14. Progress in the mechanistic understanding of NETs formation in cancer.Medical oncology (Northwood, London, England) · 2025
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 1 country.

Tongfei LiuNeuroscience Initiative, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA.
Bing ZhuNeuroscience Initiative, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA.
Yan LiuNeuroscience Initiative, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA.
Xiaoming ZhangNeuroscience Initiative, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA.
Jun YinNeuroscience Initiative, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA.
Xiaoguang LiNeuroscience Initiative, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA.
LuLin JiangNeuroscience Initiative, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA.
Andrew P HodgesNeuroscience Initiative, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA.
Sara Brin RosenthalCenter for Computational Biology and Bioinformatics, University of California, San Diego School of Medicine, La Jolla, CA.
Lisa ZhouNeuroscience Initiative, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA.
Joel YanceyNeuroscience Initiative, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA.
Amanda McQuadeInstitute for Memory Impairments and Neurological Disorders, University of California, Irvine, Irvine, CA.
Mathew Blurton-JonesInstitute for Memory Impairments and Neurological Disorders, University of California, Irvine, Irvine, CA.
Rudolph E TanziDepartment of Neurology, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA.
Timothy Y HuangNeuroscience Initiative, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA.
Huaxi XuNeuroscience Initiative, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA.
Sanford Burnham Prebys Medical Discovery Institute · USUniversity of California, Irvine · USHarvard University · USUniversity of California San Diego · US

Funding

Tumor Microenvironment and Cancer ImmunologyP30CA030199 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI Michael Jackson · 1985 to 2026
$107.2M
UC Irvine Alzheimer's Disease Research Center Induced Pluripotent Stem Cell CoreP50AG016573 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI LAFERLA, FRANK M · 2000 to 2019
$37.0M
The Alzheimer's Disease Research Center at the University of California, IrvineP30AG066519 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI Crystal M. Glover · 2020 to 2026
$27.9M
Molecular pathobiology of soluble TREM2 in Alzheimer's disease.RF1AG056130 · NIA · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI HUANG, TIMOTHY YIKAI, ZHAO, NA · 2017 to 2023
$6.8M
Regulation of Protein Trafficking in NeurodegenerationR01NS046673 · NINDS · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI XU, HUAXI · 2003 to 2018
$5.8M
BAC Transgenic Mouse Models of TREM2 to Study Neuroprotective Mechanisms in ADRF1AG056114 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI YANG, XIANGDONG WILLIAM · 2017 to 2017
$4.1M
The Role of Appoptosin in Alzheimer's Disease and Other TauopathiesR01AG038710 · NIA · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI XU, HUAXI · 2011 to 2019
$3.9M
Novel roles for the Alzheimer's Disease (AD) risk gene, SORLA in neuroprotection in ADR01AG061875 · NIA · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI HUANG, TIMOTHY YIKAI · 2018 to 2022
$3.4M
Characterizing neuroprotective roles for SNX27 signaling pathways in AD and DSRF1AG044420 · NIA · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI HUANG, TIMOTHY YIKAI · 2018 to 2018
$2.4M
Roles of SN27 in regulating glutamate receptors during neurodegenerationR01AG044420 · NIA · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI XU, HUAXI · 2013 to 2017
$2.0M
Manipulating DNA repair enzymes to examine the interactions between aging and Alzheimers disease with iPSC-derived microgliaR01AG056303 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI BLURTON-JONES, MATHEW MARK · 2017 to 2021
$1.9M
The role of TREM2 in human microglial function and Alzheimer disease pathogenesisRF1AG048099 · NIA · UNIVERSITY OF CALIFORNIA-IRVINE · PI BLURTON-JONES, MATHEW MARK · 2014 to 2014
$1.9M
NCI NIH HHS P30 CA030199NIA NIH HHS P30 AG066519NIA NIH HHS P50 AG016573NIA NIH HHS R01 AG038710NIA NIH HHS R01 AG044420NIA NIH HHS R01 AG056303NIA NIH HHS R01 AG061875NIA NIH HHS R21 AG059217NIA NIH HHS RF1 AG044420NIA NIH HHS RF1 AG048099NIA NIH HHS RF1 AG056114NIA NIH HHS RF1 AG056130NINDS NIH HHS R01 NS046673
6 · The paper itself

Abstract

Variations in many genes linked to sporadic Alzheimer's disease (AD) show abundant expression in microglia, but relationships among these genes remain largely elusive. Here, we establish isogenic human ESC-derived microglia-like cell lines (hMGLs) harboring AD variants in CD33, INPP5D, SORL1, and TREM2 loci and curate a comprehensive atlas comprising ATAC-seq, ChIP-seq, RNA-seq, and proteomics datasets. AD-like expression signatures are observed in AD mutant SORL1 and TREM2 hMGLs, while integrative multi-omic analysis of combined epigenetic and expression datasets indicates up-regulation of APOE as a convergent pathogenic node. We also observe cross-regulatory relationships between SORL1 and TREM2, in which SORL1R744X hMGLs induce TREM2 expression to enhance APOE expression. AD-associated SORL1 and TREM2 mutations also impaired hMGL Aβ uptake in an APOE-dependent manner in vitro and attenuated Aβ uptake/clearance in mouse AD brain xenotransplants. Using this modeling and analysis platform for human microglia, we provide new insight into epistatic interactions in AD genes and demonstrate convergence of microglial AD genes at the APOE locus.

Indexed as

Genetic VariationAlzheimer DiseaseAmyloid beta-PeptidesAnimalsApolipoproteins EBrainCell DifferentiationCell LineChromatinEpigenesis, GeneticGene Regulatory NetworksGene TargetingGenetic LociHuman Embryonic Stem CellsHumansMice, TransgenicAmyloid beta-PeptidesApolipoproteins EChromatinMutant ProteinsProteome

Identifiers

PMID32941599
PMCPMC7953740
OpenAlexW3084968401

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.